© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Formulary
How COVID-19 Is Affecting Those with Opioid Use Disorder
December 02, 2020
As the world remains battling the coronavirus pandemic, there are still significant and unmet needs for those fighting chronic conditions and disorders like opioid use disorder (OUD).
FDA Updates: Approvals in Rare Disorders; Expanded Approval for Flu Treatment
November 29, 2020
FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.
Insurers Take up Mantle to Ensure Immunizations
November 23, 2020
Health plans build strategies to ensure their beneficiaries have easy access to and receive vital immunizations.
COVID-19 Updates: Trump Adviser Says Vaccines Could Ship Quickly; FDA Grants Emergency Use for Regeneron Cocktail
November 22, 2020
If Pfizer's vaccine gets an emergency use authorization, it could reach sites designated by states within a day.
FDA Updates: Alkermes Gets CRL on Manufacturing Issues; Missed Deadline on Liso-Cel; Lupin Seeks New Solosec Indication
November 17, 2020
Manufacturing issue creates setback for Alkermes on much-anticipated therapy that mitigates weight gain.
FDA Updates: COVID-19 Drug Approval, Priority Review for Tagrisso in New Indication
October 25, 2020
Gilead's Veklury gets full approval; AstraZeneca's Tagrisso heads toward second indication in NSCLC; another use for experimental antifungal therapy.
FDA Updates: ALKS 3831 Wins Joint Panel Nod; Regeneron, Lilly Seek EUAs for Anti-COVID Antibodies
October 11, 2020
The PDUFA date for Alkermes' combination therapy is November 15, 2020.
Real-World Evidence: A Reality Check
September 29, 2020
Can data mined from EHRs match that from the gold standard, randomized clinical trials?
FDA Updates: Approval to Treat Rare Blood Disorders; Label Change for Benzodiazepines
September 27, 2020
Approval for treatment of HES, update to address addictive nature of benzodiazepines.
FDA Update: Report Claims “Power Grab,” Dems Say Hahn Blocked From Testifying
September 20, 2020
Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.